ReCode Therapeutics Presents Encouraging Preclinical Data from mRNA Therapeutics Program in PCD at 2021 PCD on the Move Virtual Scientific Conference ...

Study confirms the ability of ReCode’s SORT LNP platform to deliver optimized, functional CFTR mRNA as an aerosol directly to specific cell targets.